Now comprising 17 complementary corporations centered on well being, magnificence, private care and meals dietary supplements, ANJAC Well being & Magnificence encompasses as many R&D websites and 24 manufacturing websites throughout Europe and North America.
With the acquisition of Slovenia-headquartered Well being Chain Group (HCG) — together with sister corporations PharmaLinea, Hermes Consilium, and ErgoPharma — ANJAC goals to open new pathways for advancing product innovation, scientific analysis, and complete service for shopper manufacturers.
Blaž Gorjup, chairman & founding father of PharmaLinea, mentioned the corporate will be capable to speed up its growth of clinically supported ideas and develop new codecs and options as it’ll profit from ANJAC’s intensive infrastructure, cross-sector experience, and R&D sources.
“PharmaLinea and Well being Chain Group was based with a easy but bold purpose: to convey extra science, integrity, and belief to the nutraceutical trade. Seeing that imaginative and prescient develop into a gaggle acknowledged the world over fills me with delight and gratitude,” he mentioned.
“Becoming a member of forces with ANJAC will enable HCG to achieve even increased whereas staying true to its values. It’s due to this sturdy basis and vivid outlook that I selected to stay a minority shareholder and proceed to be obtainable to the corporate because it strikes ahead. My honest thanks go to everybody who has contributed to this journey.”
PharmaLinea develops and manufactures clinically supported personal label meals dietary supplements. Its portfolio of premium turnkey nutraceutical merchandise covers therapeutic areas together with iron deficiency, ladies’s well being, bones & joints, hydration, and extra, throughout codecs comparable to capsules, tablets, liquids, and powders.
Mother or father firm HCG combines three sister corporations with presence throughout greater than 40 markets worldwide and permitting it to cowl ingredient manufacturing, distribution, science, and advertising session, in a vertically built-in mannequin, thereby controlling the complete worth chain from ingredients to finished products.
“Turning into a part of ANJAC Well being & Magnificence represents each an awesome milestone and a robust affirmation of how far we’ve come — the end result of a few years of arduous work in establishing our firm, our processes, our community, and our product pipeline,“ mentioned Anton Oražem, CEO of PharmaLinea.
He added: “With ANJAC’s intensive community throughout the well being and wonder industries, PharmaLinea will achieve entry to new applied sciences, new innovation prospects, and new companions — all of which can additional strengthen our skill to ship premium, clinically substantiated complement options to our purchasers.”
Complete manufacturing accomplice
Based in 2008, ANJAC Well being & Magnificence Group has a consolidated workforce of greater than 3,300 and an anticipated turnover of almost €800million in 2025, positioning it as a number one complete R&D and manufacturing accomplice for pharmaceutical laboratories, magnificence and wellness manufacturers.
HCG’s sturdy advertising, scientific and regulatory experience, significantly by way of PharmaLinea, will allow ANJAC to help its purchasers from product conception to market launch, combining shopper insights, international developments, and distinctive scientific validation.
With the newest acquisition, the agency goals to bolster its international place within the nutraceutical market.
“This partnership displays our sturdy ambitions within the well being and pharma phase, our technique in clinically backed meals and nutraceuticals options and the continued acceleration of our worldwide development,” mentioned Aurélien Chaufour, President of the ANJAC Group. “We share with HCG a typical imaginative and prescient: Delivering revolutionary, high-performance options with a premium stage of service acknowledged by our purchasers.”
